Article Information
PubMed
Print ISSN
Online ISSN
History
- Received December 26, 2018
- Accepted April 1, 2019
- Published online July 8, 2019.
Article Versions
- Earlier version (June 10, 2019 - 07:27).
- Earlier version (June 11, 2019 - 05:37).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2019 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license.
Author Information
- Hikaru Ueno,
- Ryo Ito,
- Shin-ichi Abe,
- Mitsugi Ookawara,
- Hirohisa Miyashita,
- Hitomi Ogino,
- Yasufumi Miyamoto,
- Tomoki Yoshihara,
- Akihiro Kobayashi,
- Yoshiyuki Tsujihata,
- Koji Takeuchi,
- Masanori Watanabe,
- Yukio Yamada,
- Tsuyoshi Maekawa,
- Nobuhiro Nishigaki⇑, and
- Yusuke Moritoh⇑
- Takeda Pharmaceutical Company Limited, Kanagawa, Japan (H.U., R.I., H.M., H.O., Y.Mi., T.Y., Y.T., K.T., N.N.); and SCOHIA PHARMA, Inc., Kanagawa, Japan (S.A., M.O., A.K., M.W., Y.Y., T.M., Y.Mo.)
- Address correspondence to:
Yusuke Moritoh, Research and Development Division, SCOHIA PHARMA, Inc., 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan. E-mail: yusuke.moritoh{at}scohia.com; or - Nobuhiro Nishigaki, Therapeutic Area General Medicine, Japan Medical Office, Takeda Pharmaceutical Company Limited. 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8686, Japan. E-mail: nobuhiro.nishigaki{at}takeda.com
Statistics from Altmetric.com
Article usage
In this issue
SCO-267, a GPR40 Full Agonist
